Adcytherix

Series-A
adcytherix.com Biotech & Healthcare Marseille, France
Total Funding Undisclosed
Latest Round Undisclosed Series-A
Last Announced Oct 16, 2025
Investors 10 Backers
Decision Makers 4 Verified

About Adcytherix

Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer. The company was founded by the previous founders of Emergence Therapeutics.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Marseille, France
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website adcytherix.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Series-A announced

    fundraisingfox.com

  2. Capital Raise

    Seed announced

    fundraisingfox.com

Investors & Backers

10
aMoon Fund
Andera Partners
Angelini Ventures
Bpifrance
Dawn Biopharma
Kurma Partners
Pontifax
Pureos Bioventures
RA Capital Management
Surveyor Capital

Funding History

2 Rounds
Series-A · Oct 16, 2025
Seed · Jun 11, 2024

Founders & Leadership

4

Carsten Dehning

Founder

Work email & phone locked Unlock →

Jack Elands

Founder, Chief Executive Officer

Work email & phone locked Unlock →

Jaime Arango

Chief Financial Officer

Work email & phone locked Unlock →

Jan Schellens

Chief Medical Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts